About Us

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio


  The latest news and information about Seattle Cancer Care Alliance.

[ Prev Page / 1 2 3 4 5 6 7 8 9 10 11 12 13 14 / Next Page ]

April 12, 2012
SCCA recently opened a Phase III open-label clinical trial to evaluate trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. The SCCA investigator for this trial is Dr. V.K. Gadi.
April 04, 2012
This star high-school athlete has her family at the center of her village, but other fans include her basketball team, students and staff at Seattle Christian High School, and care providers at Seattle Cancer Care Alliance. She was treated for a rare disease – acute promyelocytic leukemia. Read Katie's story.
March 21, 2012
Seattle Cancer Care Alliance and UW Medicine received silver awards from the Leaders In Health Care program at Seattle Business Magazine. Judges singled out SCCA for “creating a network stretching across Washington, Alaska and Montana.”
March 12, 2012
Moody's Investors Service has upgraded Seattle Cancer Care Alliance's (SCCA) long-term revenue bond rating to A2 from A3. The rating applies to the Series 2008 bonds issued by the Washington Health Care Facilities Authority. The outlook is stable.

[ Prev Page / 1 2 3 4 5 6 7 8 9 10 11 12 13 14 / Next Page ]